Zobrazeno 1 - 10
of 4 131
pro vyhledávání: '"Ziemiecki, A."'
Autor:
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M. Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Hadi Beyhaghi, Seth Toback
Publikováno v:
Vaccines, Vol 12, Iss 7, p 802 (2024)
Participants in studies investigating COVID-19 vaccines commonly report reactogenicity events, and concerns about side effects may lead to a reluctance to receive updated COVID-19 vaccinations. A real-world, post hoc analysis, observational 2019nCoV-
Externí odkaz:
https://doaj.org/article/4a6215e46a214139a474118ea9ab0af3
Autor:
Richard H. Osborne, Lauren M. Nelson, Sheri Fehnel, Nicole Williams, Randall H. Bender, Ryan Ziemiecki, Efi Gymnopoulou, Els De Paepe, Yannick Vandendijck, Lindsey Norcross, Esther Heijnen, Gabriela Ispas, Christy Comeaux, Benoit Callendret, Eric K. H. Chan, Jane A. Scott
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract Background The Respiratory Infection Intensity and Impact Questionnaire (RiiQ™) is a patient-reported outcome measure designed to assess symptoms and impacts of respiratory syncytial virus (RSV) infection. This study evaluated the construc
Externí odkaz:
https://doaj.org/article/5b724d2c15ed41cd898aa8d9498f4137
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M. Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Angela Miller, Seth Toback
Publikováno v:
Vaccines, Vol 12, Iss 1, p 83 (2024)
As SARS-CoV-2 variants continue to emerge, vaccination remains a critical tool to reduce the COVID-19 burden. Vaccine reactogenicity and the impact on work productivity/daily activities are recognized as contributing factors to vaccine hesitancy. To
Externí odkaz:
https://doaj.org/article/a733523b797943a093085e517ba4b0e2
Publikováno v:
Historische Zeitschrift, 1881 Jan 01. 45(2), 329-330.
Externí odkaz:
https://www.jstor.org/stable/27593436
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Catherine B. Johannes, Daniel C. Beachler, J. Bradley Layton, Heather E. Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall-Vila, Phillip R. Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia Gilsenan
Publikováno v:
Drug Safety. 46:157-174
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor approved to treat type 2 diabetes mellitus (T2DM), among other conditions. When dapagliflozin was approved in Europe for treating T2DM (2012), potential safety concerns regarding its effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ebfbe422918481ffd13833f3c8960a
https://doi.org/10.1007/s40264-022-01263-3
https://doi.org/10.1007/s40264-022-01263-3
Autor:
Osborne, Richard H., Nelson, Lauren M., Fehnel, Sheri, Williams, Nicole, Bender, Randall H., Ziemiecki, Ryan, Gymnopoulou, Efi, De Paepe, Els, Vandendijck, Yannick, Norcross, Lindsey, Heijnen, Esther, Ispas, Gabriela, Comeaux, Christy, Callendret, Benoit, Chan, Eric K. H., Scott, Jane A.
Publikováno v:
Journal of Patient-Reported Outcomes; 6/1/2023, Vol. 7 Issue 1, p1-10, 10p
Autor:
Kueng, Peter, Nikolova, Zariana, Djonov, Valentin, Hemphill, Andrew, Rohrbach, Valeria, Boehlen, Dominik, Zuercher, Gisela, Andres, Anne-Catherine, Ziemiecki, Andrew
Publikováno v:
The Journal of Cell Biology, 1997 Dec . 139(7), 1851-1859.
Externí odkaz:
https://www.jstor.org/stable/1618372
Autor:
Carolina Moro Titton, Marcio Torikachvili, Heloísa M. C. Rêgo, Eduardo F. Medronha, Enio Ziemiecki Junior, Carolina Ribas, Carlos Germano Ceratti, Angelo Alves de Mattos, Cristiane Valle Tovo
Publikováno v:
Revista da Associação Médica Brasileira, Volume: 69, Issue: 4, Article number: e20220944, Published: 14 APR 2023
SUMMARY OBJECTIVE: The aim of the present study was to evaluate the outcomes of cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt. METHODS: A retrospective longitudinal observational study was carried out evaluating 38 cirrh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::349036e4247d023b96ada94baf240d34
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302023000400601&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302023000400601&lng=en&tlng=en
